+ Translate

The lymphatics of the prostate gland and their role in the spread of prostatic carcinoma

, : The lymphatics of the prostate gland and their role in the spread of prostatic carcinoma. Annals of the Royal College of Surgeons of England 61(2): 114-122

The results of research are reported which provide conclusive evidence of the presence of functioning intraprostatic lymphatics. The hypothesis that the prostate is an 'immunologically privileged site' devoid of demonstrable intraprostatic lymphatics is no longer valid. Intraglandular metastases via the intraprostatic lymphatics might be responsible for the multifocal presentation in prostatic carcinoma. Lymphatic spread is a primary event in a significant number of cases. The conventional separation of modes of spread as haematogenous and lymphatic seems artificial and physiologically unsound, as tumour cells tend to recycle from one system to another. The application of clinical prostatolymphography as a diagnostic tool in N-staging and as a potential therapeutic adjunct, using a suitable radioisotope, in the management of prostatic carcinoma has to be assessed.

(PDF 0-2 workdays service)

Accession: 006712537

PMID: 434749

Submit PDF Full Text: Here

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:

Related references

Cohen, R.J.; Shannon, B.A.; Weinstein, S.L., 2007: Intraductal carcinoma of the prostate gland with transmucosal spread to the seminal vesicle: a lesion distinct from high-grade prostatic intraepithelial neoplasia. Intraductal carcinoma of the prostate (IDC-P) gland represents an intraluminal neoplastic proliferation that is distinct from high-grade prostatic intraepithelial neoplasia (HG-PIN) and almost always coexists with large-volume, high-stage, and hi...

van Dieijen-Visser, M.P.; Delaere, K.P.; Gijzen, A.H.; Brombacher, P.J., 1988: A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland. Serum prostatic-specific antigen (PSA) and prostatic acid phosphatase (PAP) were determined simultaneously in 241 patients presented to the Urology Department. The patients consisted of 140 prostatic carcinoma patients (34 newly diagnosed and 106...

Masubuchi Y.; Watanbe M.; Kumai T.; Tanaka M.; Akaike M.; Hirai M., 1989: Fundamental studies of prostatic carcinoma report 36 submaxillary gland modulates the growth response to the prostatic fibrous sarcoma implanted into normal anterior prostate in rats. Japanese Journal of Pharmacology 49(SUPPL): 329P

Takenaka I.; Fukuda K.; Hamamoto R.; Inoue A.; Rii C., 1980: 4 autopsy cases of carcinoma of the prostate a study of the spread from prostatic cancer. Metastatic foci were studied in 4 recent cases of prostatic carcinoma subjected to autopsy and 300 cases selected from the Annual of the Pathological Autopsy Cases in Japan. Lymph nodes and bone were the most frequent metastatic foci followed by t...

Cihak, R.W.; Haas, R.; Koenen, C.T.; Chinchinian, H., 1980: Metastatic renal carcinoma to the prostate gland: presentation as prostatic hypertrophy. A rare instance of renal cell carcinoma metastatic to the prostate gland is described. The prostatic metastases caused acute urinary retention and were clinically thought to represent benign prostatic hypertrophy. Histologic examination of the tra...

Cristol, D.S.; Emmett, J.L., 1944: The incidence of coincident pro-static calculi, prostatic hyperplasia and carcinoma of the prostate gland. From 1938-1942 incl. in 4,136 prostatic hyperplasia cases, calculi were also present in 288 or 7%. During the same period in 686 cases of prostatic carcinoma, calculi were present in 43 or 6.3%. The latter number is in disagreement with the common...

Jones, E.C.; Young, R.H., 1994: The differential diagnosis of prostatic carcinoma. Its distinction from premalignant and pseudocarcinomatous lesions of the prostate gland. Prostate gland specimens account for a significant percentage of diagnostically challenging cases in surgical pathology practice. The understanding of prostate pathology has progressed, and the differential diagnosis of prostatic carcinoma has exp...

Schnorr, V.D.; Guddat, H.M.; Neuser, D., 1975: First experiences with the transrectal suction biopsy of the prostate gland for the cytological diagnosis of prostatic carcinoma. Zeitschrift für Arztliche Fortbildung 69(5): 229-231

Kim, E.D.; Smith, N.D.; Grayhack, J.T., 1995: Prostate specific antigen in the expressed prostatic fluid of men with benign prostatic hyperplasia and prostate carcinoma. Purpose: We tested the hypothesis that the histochemically demonstrated prostate specific antigen (PSA) content of prostate carcinoma cells does not necessarily reflect PSA production and secretion by evaluating expressed prostatic fluid. Material...

Okhrits, V.E.; bogdanov, A.B.; Veliev, E.I., 2010: The role of combined treatment of prostatic gland after biopsy of the prostate for an elevated PSA level. Benign prostatic hyperplasia and prostatic cancer have a significant effect of men's health, quality of life and death rate. Recent researches propose algorithms for treatment of benign prostatic hyperplasia which help determine optimal manag...